Press release from Companies: DanCann Pharma A/S publishes a supplement to the prospectus for the rights issue

Press release from Companies: DanCann Pharma A/S publishes Q3-2022 report

Press release from Companies: DanCann Pharma A/S signs binding agreement with Polish company Storkpharm worth more than DKK 40 million

Press release from Companies: DanCann Pharma A/S targeting annual revenue of approx. DKK 60-100 million – and with several new partner agreements in the pipeline

Press release from Companies: DanCann Pharma A/S: The subscription period in DanCann Pharma’s Rights Issue begins today

Press release from Companies: DanCann Pharma A/S: Exciting developments in Germany regarding legalization of cannabis

Market Notices: Market Notice 174/22 – Information regarding the rights issue from DanCann Pharma A/S

Press release from Companies: DanCann Pharma A/S brings forward the release of the quarterly report for Q3 2022

Press release from Companies: Board of Directors in DanCann Pharma A/S has resolved on a partially (77 percent) secured Rights Issue of approximately DKK 28.5 million and publishes prospectus

Press release from Companies: Board of Directors in DanCann Pharma A/S has resolved on a partially (77 percent) secured Rights Issue of approximately DKK 28.5 million and publishes prospectus

Press release from Companies: DanCann Pharma A/S: Upcoming legalization in the US and Germany will have a major impact on the acceptance of cannabis worldwide

Press release from Companies: DanCann Pharma A/S: Upcoming legalization in the US and Germany will have a major impact on the acceptance of cannabis worldwide